NAT. PHOS.

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: NAT. PHOS.
Generic name: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Manufacturer: Hyland's Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 9ad86f9f-df9e-4e5c-bce4-571e1da44145
SPL ID: f0314b46-2a29-a3ec-e053-2995a90af4f2
Version: 4
Effective date: 2022-12-19
Source export date: 2026-10-27
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/977776a6cc37ec1c77259da8a93ae161850a3aa120341096e5a03428b84d016b/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:55:30

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		NAT. PHOS.	openfda.brand_name
generic name		SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	openfda.generic_name
manufacturer name		Hyland's Inc.	openfda.manufacturer_name
ndc	package	54973-6436-2	openfda.package_ndc
ndc	package	54973-6436-1	openfda.package_ndc
ndc	product	54973-6436	openfda.product_ndc
ndc11	package	54973643601	derived:openfda.package_ndc
ndc11	package	54973643602	derived:openfda.package_ndc
spl id		f0314b46-2a29-a3ec-e053-2995a90af4f2	id
spl set id		9ad86f9f-df9e-4e5c-bce4-571e1da44145	set_id
unii		22ADO53M6F	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use if imprinted cap band is broken or missing. If symptoms persist for more than 7 days or worsen, contact a licensed health care provider. If you are pregnant or nursing, seek the advice of a licensed health care provider before using this product. Keep all medications out of the reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.